Answers are grounded in this paper and cite their sources.
Objectives: We have previously demonstrated association of the TNF Receptor Superfamily 6B gene (TNFRSF6B) encoding for DcR3, with Inflammatory Bowel Disease (IBD).Here we investigate the possible immuno-modulation mediated by DcR3 in EBV transformed cell lines from patient with and without risk variants in TNFRSF6B (rs2315008), in comparison with controls.Methods: Expression of DcR3 and its kinetics were examined by immunoblot analysis in whole cell lysates from EBV transformed control and patient derived cell lines of different genotype background for rs2315008 (AA, AT, TT).Cell proliferation and cell death was measured by Microtiter-tetrazolium (MTT) based assay.Nuclear factor kB (NF-kB) kinetics was determined by immunoblot analysis of cytoplasm and nuclear extracts in a time course experiment.Caspase8, caspase9, caspase3, and Bcl2 expression were analyzed by western blots.DcR3 knockdown was performed using specific DcR3 siRNA.EBV cell lines from IBD patients harboring risk variants in the TNFRSF6B gene exhibit differential pattern of DcR3 expression and NF-κB activation and promote inflammation in Crohn's Disease (CD). Results:We have investigated the immuno-modulatory role of DcR3 in EBV transformed cell lines from patient with and without risk variants in TNFRSF6B.DcR3 induced rapid activation of nuclear factor κB (NF-κB) for all genotype states.However, EBV transformed cell lines derived from IBD patients harboring a risk variant in TNFRSF6B (A allele of the rs2315008 SNP) exhibit differential pattern of DcR3 expression and NF-κB kinetics in comparison with wild type.siRNAmediated knockdown post 24hrs of nucleofection resulted in decreased DcR3 expression, increased cell death and decreased cell proliferation, effects that were also genotype-dependent.EBV cell lines from IBD patients harboring risk variants in the TNFRSF6B gene exhibit differential pattern of DcR3 expression and NF-κB activation and promote inflammation in Crohn's disease by inhibiting FasL-induced apoptosis.Conclusions: EBV cell lines from IBD patients harboring risk variants in the TNFRSF6B gene exhibit differential pattern of DcR3 expression and NF-κB activation and promote inflammation in Crohn's disease (CD).We propose that pathogenic inflammation in CD may be in part be the result of non-canonical developmental signals impinging on a NF-B signaling module with an altered homeostasis of IκB proteins.
No takes yet. Share an insight, caveat, or question.
Pandey et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: